RPL17 and Sepsis: Huang et al. found that PD-1 not only may be a marker of the developing of macrophages/monocytes dysfunction during sepsis but may also be a potential therapeutic target for designing measures to modulate the innate immune response, thereby preventing the detrimental effects of sepsis [20].